UBS Group’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Sell |
199,679
-8,188
| -4% | -$16.7K | ﹤0.01% | 4999 |
|
|
2025
Q1 | $339K | Buy |
207,867
+30,893
| +17% | +$50.4K | ﹤0.01% | 4941 |
|
|
2024
Q4 | $324K | Buy |
176,974
+163,259
| +1,190% | +$299K | ﹤0.01% | 4978 |
|
|
2024
Q3 | $79.3K | Sell |
13,715
-13,676
| -50% | -$79K | ﹤0.01% | 5324 |
|
|
2024
Q2 | $221K | Buy |
27,391
+25,475
| +1,330% | +$206K | ﹤0.01% | 4476 |
|
|
2024
Q1 | $26.6K | Sell |
1,916
-50,559
| -96% | -$702K | ﹤0.01% | 5618 |
|
|
2023
Q4 | $26.8K | Sell |
52,475
-2,635
| -5% | -$1.34K | ﹤0.01% | 5715 |
|
|
2023
Q3 | $21.4K | Buy |
55,110
+47,992
| +674% | +$18.7K | ﹤0.01% | 5631 |
|
|
2023
Q2 | $3.18K | Sell |
7,118
-791,994
| -99% | -$354K | ﹤0.01% | 6575 |
|
|
2023
Q1 | $655K | Sell |
799,112
-117,528
| -13% | -$96.4K | ﹤0.01% | 3514 |
|
|
2022
Q4 | $1.43M | Buy |
916,640
+614,013
| +203% | +$958K | ﹤0.01% | 2847 |
|
|
2022
Q3 | $522K | Sell |
302,627
-301,618
| -50% | -$520K | ﹤0.01% | 3330 |
|
|
2022
Q2 | $1.05M | Sell |
604,245
-1,035,767
| -63% | -$1.79M | ﹤0.01% | 2858 |
|
|
2022
Q1 | $5.89M | Buy |
1,640,012
+817,297
| +99% | +$2.93M | ﹤0.01% | 1801 |
|
|
2021
Q4 | $4.11M | Buy |
822,715
+365,577
| +80% | +$1.82M | ﹤0.01% | 2275 |
|
|
2021
Q3 | $3.27M | Buy |
457,138
+360,844
| +375% | +$2.58M | ﹤0.01% | 2380 |
|
|
2021
Q2 | $892K | Sell |
96,294
-11,747
| -11% | -$109K | ﹤0.01% | 3340 |
|
|
2021
Q1 | $1M | Buy |
108,041
+50,726
| +89% | +$471K | ﹤0.01% | 3351 |
|
|
2020
Q4 | $507K | Buy |
57,315
+3,173
| +6% | +$28.1K | ﹤0.01% | 3669 |
|
|
2020
Q3 | $628K | Buy |
54,142
+3,319
| +7% | +$38.5K | ﹤0.01% | 3236 |
|
|
2020
Q2 | $1.37M | Buy |
50,823
+17,673
| +53% | +$476K | ﹤0.01% | 2573 |
|
|
2020
Q1 | $246K | Sell |
33,150
-93,632
| -74% | -$695K | ﹤0.01% | 3744 |
|
|
2019
Q4 | $419K | Buy |
126,782
+53,283
| +72% | +$176K | ﹤0.01% | 4035 |
|
|
2019
Q3 | $151K | Buy |
73,499
+56,449
| +331% | +$116K | ﹤0.01% | 4562 |
|
|
2019
Q2 | $50K | Sell |
17,050
-262,712
| -94% | -$770K | ﹤0.01% | 5070 |
|
|
2019
Q1 | $1.04M | Sell |
279,762
-229,479
| -45% | -$856K | ﹤0.01% | 2898 |
|
|
2018
Q4 | $2.04M | Buy |
509,241
+235,965
| +86% | +$944K | ﹤0.01% | 2425 |
|
|
2018
Q3 | $1.52M | Sell |
273,276
-14,084
| -5% | -$78.3K | ﹤0.01% | 2820 |
|
|
2018
Q2 | $1.13M | Sell |
287,360
-155,533
| -35% | -$609K | ﹤0.01% | 2982 |
|
|
2018
Q1 | $2.09M | Buy |
442,893
+270,373
| +157% | +$1.27M | ﹤0.01% | 2524 |
|
|
2017
Q4 | $713K | Sell |
172,520
-128,972
| -43% | -$533K | ﹤0.01% | 3227 |
|
|
2017
Q3 | $1.91M | Buy |
301,492
+122,082
| +68% | +$774K | ﹤0.01% | 2528 |
|
|
2017
Q2 | $1.41M | Buy |
179,410
+18,000
| +11% | +$141K | ﹤0.01% | 2670 |
|
|
2017
Q1 | $1.07M | Sell |
161,410
-98,348
| -38% | -$651K | ﹤0.01% | 2787 |
|
|
2016
Q4 | $1.8M | Buy |
259,758
+58,553
| +29% | +$406K | ﹤0.01% | 2361 |
|
|
2016
Q3 | $1.88M | Sell |
201,205
-306
| -0.2% | -$2.85K | ﹤0.01% | 2274 |
|
|
2016
Q2 | $1.86M | Buy |
201,511
+68,661
| +52% | +$635K | ﹤0.01% | 2233 |
|
|
2016
Q1 | $1.16M | Sell |
132,850
-19,893
| -13% | -$173K | ﹤0.01% | 2545 |
|
|
2015
Q4 | $1.03M | Buy |
152,743
+10,043
| +7% | +$67.5K | ﹤0.01% | 2674 |
|
|
2015
Q3 | $825K | Buy |
142,700
+17,050
| +14% | +$98.6K | ﹤0.01% | 2791 |
|
|
2015
Q2 | $1.03M | Buy |
125,650
+11,350
| +10% | +$92.6K | ﹤0.01% | 2781 |
|
|
2015
Q1 | $933K | Sell |
114,300
-52,613
| -32% | -$429K | ﹤0.01% | 2836 |
|
|
2014
Q4 | $1.53M | Buy |
+166,913
| New | +$1.53M | ﹤0.01% | 2433 |
|